EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer

Yuanyuan Zhang, Hongyan Chen, Hongnan Mo, Ning Zhao, Xiaoying Sun, Baolin Liu, Ranran Gao, Binghe Xu, Zemin Zhang, Zhihua Liu, Fei Ma

Cancer Cell · 2025-03 · 43 (3) · 446-463.e7

DOI: 10.1016/j.ccell.2025.01.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-03. Verfasst von Yuanyuan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of M…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immune Checkpoint Inhibitors, B7-H1 Antigen, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsImmune Checkpoint InhibitorsB7-H1 AntigenAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsFemalePaclitaxelMiceAntibodies, Monoclonal, HumanizedTumor MicroenvironmentMast CellsCD8-Positive T-LymphocytesAlbumins

Stichwörter der Autor:innen

chemotherapyimmune checkpoint blockademast cellspro-inflammatory macrophagessingle-cell RNA sequencingstem-like T cellstriple-negative breast cancertumor microenvironment

Substanzen

PaclitaxelImmune Checkpoint InhibitorsB7-H1 AntigenAntibodies, Monoclonal, HumanizedCD274 protein, humanatezolizumab130-nm albumin-bound paclitaxelAlbumins

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, Chin…
  • Department of Medical Oncology, Cancer Hospital of HuanXing, ChaoYang District, Beijing 100005, China.
  • BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.
  • BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China. Electronic address: zemin@pku.edu.cn.

Zitieren

APA

Zhang, Y., Chen, H., Mo, H., Zhao, N., Sun, X., Liu, B., Gao, R., Xu, B., Zhang, Z., Liu, Z., & Ma, F. (2025). Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer. Cancer Cell, 43(3), 446-463.e7. https://doi.org/10.1016/j.ccell.2025.01.007

Vancouver

Zhang Y, Chen H, Mo H, Zhao N, Sun X, Liu B, et al. Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer. Cancer Cell. 2025;43(3):446-463.e7. doi:10.1016/j.ccell.2025.01.007

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuanyuan and Chen, Hongyan and Mo, Hongnan and Zhao, Ning and Sun, Xiaoying and Liu, Baolin and Gao, Ranran and Xu, Binghe and Zhang, Zemin and Liu, Zhihua and Ma, Fei},
  title = {Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {3},
  pages = {446--463.e7},
  doi = {10.1016/j.ccell.2025.01.007}
}
Kostenlos starten →